Contemporary Cardiology

Antithrombotic Drug Therapy in Cardiovascular Disease

Editors: Askari, Arman T., Lincoff, A Michael (Eds.)

  • Comprehensive overview of the pathophysiology, including the genetics, of arterial and venous thrombosis
  • Detailed, up-to-date data regarding the use of the currently available antithrombotic therapies for commonly-encountered clinical situations in Cardiology
  • Provides rapid access to instructional discussions of various therapies
see more benefits

Buy this book

eBook $229.00
price for USA (gross)
  • ISBN 978-1-60327-235-3
  • Digitally watermarked, DRM-free
  • Included format: EPUB, PDF
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Hardcover $289.00
price for USA
  • ISBN 978-1-60327-234-6
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
Softcover $289.00
price for USA
  • ISBN 978-1-62703-797-6
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
About this book

Substantial morbidity and mortality remains associated with thrombotic events has stimulated the rapid expansion of the available armamentarium to combat pathologic thrombosis. Pathologic thrombosis plays an essential role in the pathogenesis of acute coronary syndromes (ACS), ischemic complications of percutaneous coronary intervention (PCI), venous thromboembolic disease, and embolic complications of arrhythmias and various cardiomyopathies. Written by experts in the field, Antithrombotic Drug Therapy in Cardiovascular Disease carefully examines individual and various combinations of the available antithrombotic regimens including fibrinolytic agents, antiplatelet therapies (aspirin, thieneopyridines, glycoprotein IIb/IIIa inhibitors), and anticogulant therapies (unfractionated heparin, low-molecular-weight heparins, direct thrombin inhibitors, and synthetic factor X inhibitors), non-ST-segment elevation (NSTE) ACS and ST-segment elevation myocardial infarction (STEMI). A detailed overview, Antithrombotic Drug Therapy in Cardiovascular Disease presents the evidence demonstrating the efficacy of available antithrombotic therapies in specific disease states such as atrial fibrillation, cardiomyopathy, valvular heart disease, and heparin-induced thrombocytopenia (HIT).

Reviews

From the reviews: Despite substantial therapeutic progress, considerable morbidity and mortality remains associated with thrombotic events but rapid expansion of the available armamentarium to combat pathologic thrombosis is nicely summarized in this excellent new book which becomes a valuable guide to improved therapy. The experts from the field, selected by its editors, survey individual and various combinations of the available antithrombotic regimens including fibrinolytic agents, antiplatelet therapies (aspirin, thieneopyridines, glycoprotein IIb/IIIa inhibitors), and anticogulant therapies (unfractionated heparin, low-molecular-weight heparins, direct thrombin inhibitors, and synthetic factor X inhibitors). The treatments discussed are up-to-date methods for management of common cardiovascular thrombotic problems designed for appropriate clinical use. Numerous illustrations, tables and figures throughout the book become particularly helpful for the reader. There are seven major divisions covered by twenty four chapters; most of which are multi-authored and include: Basic Principles, Antithrombotic Therapy for Stable Coronary Atherosclerotic Disease, Antithrombotic Therapy for NSTE ACS, Antithrombotic Therapy for STEMI. Antithrombotic Therapy in Interventional Cardiology, Antithrombotic Therapy in Venous Thromboembolism, and Clinical Considerations. The coagulationist should find this text to be a valuable addition to his/her office reference book shelf. William H Wehrmacher MD FACP FACC Harry L Messmore MD FACP from Comprehensive Therapy - 2010 “The chapter authors of this multiauthored book on antithrombotic drug therapy in cardiovascular disease are national and international thought leaders in their respective fields. … The intended audience includes medical students, allied health professionals, physicians in training, and cardiovascular physicians. … This will be a valuable resource for healthcare providers in the field of cardiovascular disease management. The authors have met their objective of providing a high quality, evidence-based review of this field.” (Timir Paul, Doody’s Review Service, March, 2009)

Table of contents (24 chapters)

  • Platelets in Arterial Thrombosis

    Plow, Edward F. (et al.)

    Pages 3-17

  • The Role of Coagulation in Arterial and Venous Thrombosis

    Kottke-Marchant, Kandice

    Pages 19-38

  • The Link Between Inflammation and Thrombosis

    Cleator, John H. (et al.)

    Pages 39-61

  • The Genetics of Thrombosis

    Shah, Svati H. (et al.)

    Pages 63-114

  • Aspirin in Primary and Secondary Prevention of Cardiovascular Disease

    Kochar, Jinesh (et al.)

    Pages 117-129

Buy this book

eBook $229.00
price for USA (gross)
  • ISBN 978-1-60327-235-3
  • Digitally watermarked, DRM-free
  • Included format: EPUB, PDF
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Hardcover $289.00
price for USA
  • ISBN 978-1-60327-234-6
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
Softcover $289.00
price for USA
  • ISBN 978-1-62703-797-6
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
Loading...

Recommended for you

Loading...

Bibliographic Information

Bibliographic Information
Book Title
Antithrombotic Drug Therapy in Cardiovascular Disease
Editors
  • Arman T. Askari
  • A Michael Lincoff
Series Title
Contemporary Cardiology
Copyright
2010
Publisher
Humana Press
Copyright Holder
Humana Press
eBook ISBN
978-1-60327-235-3
DOI
10.1007/978-1-60327-235-3
Hardcover ISBN
978-1-60327-234-6
Softcover ISBN
978-1-62703-797-6
Series ISSN
2196-8969
Edition Number
1
Number of Pages
XIII, 475
Topics